
iRhythm Technologies (IRTC) Stock Forecast & Price Target
iRhythm Technologies (IRTC) Analyst Ratings
Bulls say
iRhythm Holdings is a digital healthcare company that focuses on providing ambulatory cardiac monitoring services. Its Zio System, which combines a patch-based wearable biosensor and proprietary software, allows for quicker and more efficient diagnosis of arrhythmias. With a strong track record of revenue growth and potential upside drivers such as international expansion and new products, this analyst believes that iRhythm has a bright future ahead with the potential for double-digit revenue growth and profitability in the coming years. However, risks include competition and reimbursement developments, and investors should carefully monitor these factors.
Bears say
iRhythm Holdings is currently facing multiple headwinds, including potential downward pressure on commercial reimbursement rates, competitive pressure from existing players, and potential underwhelming performance of key product launches, all of which could hinder future revenue growth and profitability. Additionally, the company is facing potential regulatory risks from FDA warnings or settlement payments. While the company's Zio system has shown promising growth, there is uncertainty surrounding the launch of their upcoming ZioMCT product. As a result, the negative outlook for this stock is rooted in concerns about the company's ability to maintain its growth trajectory and meet its long-term financial targets.
This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.
iRhythm Technologies (IRTC) Analyst Forecast & Price Prediction
Start investing in iRhythm Technologies (IRTC)
Order type
Buy in
Order amount
Est. shares
0 shares